Ativo Circulante Alterar Data
AbbVie USD 37.48B 3.81B 2026-09
Amgen USD 34.36B 598M 2026-09
AstraZeneca USD 31.45B 3.48B 2026-09
Biogen USD 7.58B 278.7M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Daiichi Sankyo JPY 2.38T 150.33B 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Genmab DKK 2.8B 228M 2026-06
Geron USD 468.74M 17.6M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
J&J USD 56.35B 3.42B 2026-09
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
MacroGenics USD 295.08M 26.61M 2026-09
Merck USD 38.94B 2.26B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Xencor USD 498.66M 24.55M 2026-09